HEALTH

 Newsweek - In 2025, more than 850,000 Americans with Medicare will benefit from lower prescription drug costs as part of the Inflation Reduction Act. In a Friday announcement, The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), said that 64 drugs covered by Medicare Part B will be subject to reduced coinsurance rates from January 1 through March 31, 2025.  The affected drugs treat serious conditions, including cancer, osteoporosis, and substance use disorder...